CYTOSEEK
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. We are a spinout company from the University of Bristol. Our novel cell membrane augmentation technology enables us to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.
CYTOSEEK
Social Links:
Industry:
Biotechnology Life Science Medical Pharmaceutical
Founded:
2017-01-01
Address:
Bristol, Bristol, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cytoseek.uk
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.38 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Font Awesome Google Apps For Business JsDelivr GoDaddy DNS
Similar Organizations
Adar Biotech
Next-generation medical technology.
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Mana Therapeutics
Next-Generation Immunotherapies
OncoScore
OncoScore - your partner for cancer tailored therapy.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Meltwind Advisory
Meltwind Advisory investment in Seed Round - Cytoseek
Parkwalk Advisors
Parkwalk Advisors investment in Seed Round - Cytoseek
Science Creates Ventures
Science Creates Ventures investment in Seed Round - Cytoseek
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Seed Round - Cytoseek
Future Planet Capital
Future Planet Capital investment in Seed Round - Cytoseek
Future Planet Capital
Future Planet Capital investment in Seed Round - Cytoseek
Parkwalk Advisors
Parkwalk Advisors investment in Seed Round - Cytoseek
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Seed Round - Cytoseek
Future Planet Capital
Future Planet Capital investment in Seed Round - Cytoseek
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Seed Round - Cytoseek
Key Employee Changes
| Date | New article |
|---|---|
| 2020-01-20 | CytoSeek appoints a CEO |
Official Site Inspections
http://www.cytoseek.uk
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cytoseek"
Cytoseek - Crunchbase Company Profile & Funding
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. We are a spinout …See details»
CytoSeek - Headquarter Location, Corporate Office Address and …
CytoSeek is Biotechnology in United Kingdom that focus on wound healing business. Founded in 2017. They cover business area such as developer, cell membrane augmentation technology, …See details»
CytoSeek - LinkedIn
CytoSeek Research Services Bristol, Bristol 1,381 followers A cell-therapy technology company developing artificial membrane-binding proteins for oncology and regenerative medicineSee details»
Cytoseek - Perriman Research Group
For more information, visit cytoseek.uk. Dr David Coe. Dr Sara Menegatti. Trained as a Stem Cell Biologist, I joined CytoSeek and its mission to improve cell therapies by using a unique cell membrane augmentation technology. My aim …See details»
Cytoseek - VentureRadar
Oct 26, 2018 CytoSeek is currently developing a range of Artificial Membrane-Binding Proteins (AMBPs) to address challenges faced by cell therapies targeting solid tumours. The constructs …See details»
CytoSeek - Overview, News & Similar companies | ZoomInfo.com
Jan 24, 2020 CytoSeek contact info: Phone number: +44 1174034035 Website: www.cytoseek.uk What does CytoSeek do? CytoSeek is a discovery stage biotech company …See details»
Cytoseek Company Profile - Office Locations, Competitors, …
Cytoseek is a cell-therapy technology company developing artificial membrane-binding proteins for oncology and regenerative medicine. The company provides a cell membrane …See details»
Cytoseek - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Seed Round - Cytoseek . 5: obfuscated. obfuscated. Parkwalk Advisors, SCVC: Nov …See details»
CytoSeek Raises £3.5m Led by Science Creates …
University of Bristol spin-out CytoSeek has raised a £3.5 million seed round to develop new cell therapies to treat solid tumours in cancer patients. The funding is led by Science Creates Ventures (SCV), Bristol’s new deep tech EIS fund …See details»
CytoSeek - F6S
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. We are a spinout company from the University of Bristol. …See details»
CytoSeek – Funding, Valuation, Investors, News
Mar 18, 2021 CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. We are a spinout company from the …See details»
November: CytoSeek | News and features | University of Bristol
CytoSeek’s deep tech will make a real impact in medicine." Further information. Bristol Private Equity Club ... Parkwalk is the largest growth EIS fund manager, backing world-changing …See details»
CytoSeek – Research Commercialisation Hub
Mar 23, 2021 University of Bristol spin-out company CytoSeek has raised £3.5 million to accelerate the development of new cell therapies to treat solid tumours in cancer patients, …See details»
Cytoseek – raises £1.1m for new cell therapies - Parkwalk Advisors
Nov 25, 2019 CytoSeek, a new spin-out from the University of Bristol, has been backed by a number of organisations as Bristol becomes recognised as a centre for biotechnology. The …See details»
CytoSeek raises £3.5m led by Science Creates Ventures
Mar 24, 2021 Search; In News, Investment, Startups • March 24, 2021 • 5 Minutes. CytoSeek raises £3.5m led by Science Creates VenturesSee details»
Cytoseek raises £3.57m ($5m) to advance its mission to develop
Mar 19, 2021 The funding round was led by Science Creates Ventures (SCV), a new early-stage Bristol-based deep tech EIS investment fund. SCV is focused on next-gen technologies that …See details»
2021: cytoseek | Bristol Cancer Research Network - University of …
CytoSeek’s technology is designed to help target the immune cells to the solid tumour and improve their cancer cell-killing ability. Solid tumours account for the majority of deaths from …See details»
Cytoseek - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Cytoseek . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. ... Cytoseek has 2 board …See details»
Cytoseek CEO and Key Executive Team | Craft.co
Cytoseek's key executives include Adam Perriman and 4 others. Adam Perriman. Director, CSO. Carolyn Porter. Director, CEO. Ben Carter. COO. Damian Marron. Non-Executive Director …See details»
CytoSeek - raises £3.57m funding round - Parkwalk Advisors
Mar 16, 2021 CytoSeek is commercialising its technology via a model that includes development and out-licence of its novel AMBP technology. The Company launched in late 2019 with an …See details»